Medtronic PLC
Change company Symbol lookup
Select an option...
MDT Medtronic PLC
TELL Tellurian Inc
PFE Pfizer Inc
AGNC Agnc Investment Corp
AAPL Apple Inc
GRTYA Guaranty Corp
SATS EchoStar Corp
$DJI Dow Jones Industrials
TIKK Tel-Instrument Electronics Corp
TEAM Atlassian Corporation PLC
Go

Health Care : Health Care Equipment & Supplies | Large Cap Blend
Based in Ireland
Company profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company's subsidiaries include Medtronic, Inc. and HeartWare International, Inc.

Postmarket

Last Trade
Delayed
$0.00
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$113.85
Day's Change
1.38 (1.23%)
Bid
--
Ask
--
B/A Size
--
Day's High
113.85
Day's Low
111.70
Volume
(Below Average)
Volume:
3,518,204

10-day average volume:
4,378,259
3,518,204

$26.8 Billion Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Global Forecast to 2025 with Abbott Labs, Medtronic and Boston Scientific Dominating - ResearchAndMarkets.com

12:19 pm ET October 14, 2020 (BusinessWire) Print

The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market By Product CM (ECG (Holter Monitor), ILR, Event Monitor)), CRM ((Defibrillator (ICD) External (AED)), Pacemaker (CRT P, Dual Chamber Pacemaker)), End User - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is Projected to Reach USD 26.8 Billion by 2025 from USD 22.1 Billion in 2020, at a CAGR of 4.0% from 2020 to 2025.

The growth of this market is driven by the increasing prevalence of cardiovascular diseases; availability of reimbursement for CM & CRM devices; the launch of innovative products by market players; increasing investments, funds, and grants for research on CM & CRM devices; and the growing preference for wearable cardiac devices. Also, measures to reduce infections caused due to CIEDs to offer an opportunity for the growth of the market during the forecast period.

ECG devices are expected to hold the largest share of the cardiac monitoring devices market in 2020

On the basis of cardiac monitoring devices by type, the market is segmented into ECG devices, event monitors, implantable loop recorders (ILRs), cardiac output monitoring (COM) devices, mobile cardiac telemetry (MCT) devices, and smart ECG monitors. In 2019, the ECG devices segment accounted for the largest share of the cardiac monitoring devices market. The large share of this segment can be attributed to technological advancements such as the incorporation of advanced algorithms and workflow improvement features, such as simplified operations, touchscreen systems, portability, wireless features, and better connectivity with cardiovascular information systems (CVIS), electronic medical records (EMRs), and ECG management systems.

Defibrillators are expected to hold the largest share of the cardiac rhythm management devices market in 2020

On the basis of cardiac rhythm management devices by type, the market is segmented into defibrillators and pacemakers. In 2019, the defibrillators segment accounted for the largest market share. This segment is also projected to register the highest CAGR during the forecast period. Factors such as technological advancements in defibrillators, rising prevalence of CVD, and growing focus on providing public-access defibrillators are driving the growth of this market.

Hospitals segment commanded the largest share of the cardiac monitoring & cardiac rhythm management devices market in 2020

By end-user, the cardiac monitoring & cardiac rhythm management devices market is segmented into hospitals; clinics, cardiac centers, and ambulatory surgery centers (ASCs); and other end users. Hospitals accounted for the largest share of the cardiac monitoring & cardiac rhythm management devices market in 2019. The large share of this segment can be attributed to factors such as the increasing prevalence of CVD, the growing number of patient visits to hospitals for diagnosis, increasing number of cardiac implant procedures, and the availability of reimbursement for these procedures across developed markets.

North America commanded the largest share of the cardiac monitoring & cardiac rhythm management devices market in 2020.

On the basis of region, the cardiac monitoring & cardiac rhythm management devices market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2019, North America commanded the largest share of the cardiac monitoring & cardiac rhythm management devices market. The large share of this market segment can be attributed to the increasing incidence of CVD, increasing healthcare expenditure, growing disposable income, growing healthcare awareness, and the availability of technologically advanced devices in the region.

Some of the major players operating in this market are Abbott Laboratories (US), Medtronic (Ireland) and Boston Scientific Corporation (US).

List of Companies Profiled in the Report

Medtronic (Ireland) Boston Scientific Corporation (US) Abbott Laboratories (US) GE Healthcare (US) BIOTRONIK (Germany) Koninklijke Philips (Netherlands) Asahi Kasei Corporation (Japan) MicroPort Scientific Corporation (China) Hill-Rom Holdings (US) Nihon Kohden (Japan) SCHILLER AG (Switzerland) BioTelemetry (US) BPL Medical Technologies (India) ACS Diagnostics (US) Shenzhen Mindray Bio-Medical Electronics (China) Lepu Medical Technology (China) Shree Pacetronix (India) OSYPKA (Germany) BTL (US) Alivecor, Inc. (US) Amiitalia (Italy) Bexen Cardio (Spain) Narang Medical Limited (India) MeTrax GmbH (Germany) Progetti Srl (Italy)

For more information about this report visit https://www.researchandmarkets.com/r/uqk90w

View source version on businesswire.com: https://www.businesswire.com/news/home/20201014005772/en/

SOURCE: Research and Markets

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.